Clinical study of etomidate emulsion combined with remifentanil in general anesthesia

Digui Weng, Menghua Huang, Runnian Jiang, Rufu Zhan, Chunni YangDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian, People's Republic of ChinaBackground: The aim of this study was to investigate and evaluate the safety, recovery time, and sid...

Full description

Bibliographic Details
Main Authors: Weng D, Huang M, Jiang R, Zhan R, Yang C
Format: Article
Language:English
Published: Dove Medical Press 2013-08-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/clinical-study-of-etomidate-emulsion-combined-with-remifentanil-in-gen-a14093
id doaj-6e0ad8c50ff14d67b3aab716e467dca5
record_format Article
spelling doaj-6e0ad8c50ff14d67b3aab716e467dca52020-11-24T22:03:09ZengDove Medical PressDrug Design, Development and Therapy1177-88812013-08-012013default771776Clinical study of etomidate emulsion combined with remifentanil in general anesthesiaWeng DHuang MJiang RZhan RYang CDigui Weng, Menghua Huang, Runnian Jiang, Rufu Zhan, Chunni YangDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian, People&#39;s Republic of ChinaBackground: The aim of this study was to investigate and evaluate the safety, recovery time, and side effects of general anesthesia with different doses of etomidate emulsion combined with remifentanil.Methods: One hundred ten patients of American Society of Anesthesiologists class 1 or 2 who underwent gynecological general anesthesia with a 1-3-hour operation time were randomly divided into the following groups: etomidate emulsion group 1 ([E1] n = 30); etomidate emulsion group 2 ([E2] n = 30); etomidate emulsion group 3 ([E3] n = 20); and propofol group ([P group] n = 30). For induction of anesthesia, 0.3 mg/kg etomidate emulsion, and the continuous remifentanil infusion also to induce anesthesia (0.1~0.3 &micro;g &middot; kg-1 &middot; min-1), was applied in all cases. Afterwards, continuous infusion of etomidate emulsion and remifentanil, respectively (E1: 10 &micro;g &middot; kg-1 &middot; min-1 and 0.1 &micro;g &middot; kg-1 &middot; min-1; E2: 15 &micro;g &middot; kg-1 &middot; min-1 and 0.2 &micro;g &middot; kg-1 &middot; min-1; E3: 20 &micro;g &middot; kg-1 &middot; min-1 and 0.2 &micro;g &middot; kg-1 &middot; min-1), and propofol (P group: 6~10 mg &middot; kg-1 &middot; h-1) were administered. Changes in blood flow kinetics and adverse reactions were noted and compared between the four groups.Results: Both arterial blood pressure (BP) and heart rate (HR) decreased after induction of anesthesia (P < 0.05). Systolic (SBP) and diastolic (DBP) BP changed only slightly, and HRs were slightly infected in E1, E2, and E3. SBP, DBP, and HR during the operation all decreased significantly in P group (P < 0.05). Muscle tremor at the time of induction occurred in 13 cases (11.8%). Following etomidate emulsion anesthesia maintenance, postoperative agitation occurred in seven cases (8.75%), lethargy in 20 cases (25%), and vomiting in 19 cases (23.75%). No adverse reactions were found in P group.Conclusion: Continuous infusion of etomidate emulsion at 10 &micro;g &middot; kg-1 &middot; minute-1 combined with remifentanil during anesthesia has the advantages of hemodynamic stability, quick wake-up, and few adverse reactions. Increasing the dose of etomidate emulsion increases the incidence of adverse reactions.Keywords: etomidate emulsion, remifentanil, general anesthesiahttp://www.dovepress.com/clinical-study-of-etomidate-emulsion-combined-with-remifentanil-in-gen-a14093
collection DOAJ
language English
format Article
sources DOAJ
author Weng D
Huang M
Jiang R
Zhan R
Yang C
spellingShingle Weng D
Huang M
Jiang R
Zhan R
Yang C
Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
Drug Design, Development and Therapy
author_facet Weng D
Huang M
Jiang R
Zhan R
Yang C
author_sort Weng D
title Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
title_short Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
title_full Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
title_fullStr Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
title_full_unstemmed Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
title_sort clinical study of etomidate emulsion combined with remifentanil in general anesthesia
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2013-08-01
description Digui Weng, Menghua Huang, Runnian Jiang, Rufu Zhan, Chunni YangDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, Fujian, People&#39;s Republic of ChinaBackground: The aim of this study was to investigate and evaluate the safety, recovery time, and side effects of general anesthesia with different doses of etomidate emulsion combined with remifentanil.Methods: One hundred ten patients of American Society of Anesthesiologists class 1 or 2 who underwent gynecological general anesthesia with a 1-3-hour operation time were randomly divided into the following groups: etomidate emulsion group 1 ([E1] n = 30); etomidate emulsion group 2 ([E2] n = 30); etomidate emulsion group 3 ([E3] n = 20); and propofol group ([P group] n = 30). For induction of anesthesia, 0.3 mg/kg etomidate emulsion, and the continuous remifentanil infusion also to induce anesthesia (0.1~0.3 &micro;g &middot; kg-1 &middot; min-1), was applied in all cases. Afterwards, continuous infusion of etomidate emulsion and remifentanil, respectively (E1: 10 &micro;g &middot; kg-1 &middot; min-1 and 0.1 &micro;g &middot; kg-1 &middot; min-1; E2: 15 &micro;g &middot; kg-1 &middot; min-1 and 0.2 &micro;g &middot; kg-1 &middot; min-1; E3: 20 &micro;g &middot; kg-1 &middot; min-1 and 0.2 &micro;g &middot; kg-1 &middot; min-1), and propofol (P group: 6~10 mg &middot; kg-1 &middot; h-1) were administered. Changes in blood flow kinetics and adverse reactions were noted and compared between the four groups.Results: Both arterial blood pressure (BP) and heart rate (HR) decreased after induction of anesthesia (P < 0.05). Systolic (SBP) and diastolic (DBP) BP changed only slightly, and HRs were slightly infected in E1, E2, and E3. SBP, DBP, and HR during the operation all decreased significantly in P group (P < 0.05). Muscle tremor at the time of induction occurred in 13 cases (11.8%). Following etomidate emulsion anesthesia maintenance, postoperative agitation occurred in seven cases (8.75%), lethargy in 20 cases (25%), and vomiting in 19 cases (23.75%). No adverse reactions were found in P group.Conclusion: Continuous infusion of etomidate emulsion at 10 &micro;g &middot; kg-1 &middot; minute-1 combined with remifentanil during anesthesia has the advantages of hemodynamic stability, quick wake-up, and few adverse reactions. Increasing the dose of etomidate emulsion increases the incidence of adverse reactions.Keywords: etomidate emulsion, remifentanil, general anesthesia
url http://www.dovepress.com/clinical-study-of-etomidate-emulsion-combined-with-remifentanil-in-gen-a14093
work_keys_str_mv AT wengd clinicalstudyofetomidateemulsioncombinedwithremifentanilingeneralanesthesia
AT huangm clinicalstudyofetomidateemulsioncombinedwithremifentanilingeneralanesthesia
AT jiangr clinicalstudyofetomidateemulsioncombinedwithremifentanilingeneralanesthesia
AT zhanr clinicalstudyofetomidateemulsioncombinedwithremifentanilingeneralanesthesia
AT yangc clinicalstudyofetomidateemulsioncombinedwithremifentanilingeneralanesthesia
_version_ 1725832874631888896